SCHEMBL23606777

SCHEMBL23606777

Clc1cccc(-c2ccc3oc(-c4ccccc4)nc3c2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.77
▸ CASP3 P42574 3/20 0.77
▸ SENP7 Q9BQF6 3/20 0.77
▸ SENP6 Q9GZR1 3/20 0.77
▸ KDM4E B2RXH2 6/20 0.60
▸ HPGD P15428 3/20 0.60
▸ ALDH1A1 P00352 3/20 0.60
▸ NFKB1 P19838 2/20 0.60
▸ NFKB2 Q00653 2/20 0.60
▸ RELA Q04206 2/20 0.60
▸ LMNA P02545 2/20 0.60
▸ PTPN2 P17706 4/20 0.59
▸ PTPN1 P18031 4/20 0.59
▸ NPC1 O15118 7/20 0.59
▸ RAB9A P51151 7/20 0.59
▸ POLB P06746 2/20 0.59
▸ SENP8 Q96LD8 2/20 0.59
▸ NPSR1 Q6W5P4 2/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2243994 0.89 SMN1; SMN2 (0.79) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL13528498 0.89 NPC1 (0.72) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24881965 0.88 SMN1; SMN2 (0.63) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24881857 0.88 SMN1; SMN2 (0.94) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL30729297 0.87 SMN1; SMN2 (1.00) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL2141073 0.87 SMN1; SMN2 (1.00) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL2244575 0.87 SMN1; SMN2 (0.70) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL7905531 0.87 SMN1; SMN2 (0.70) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL19846132 0.84 SMN1; SMN2 (0.66) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL19846131 0.84 SMN1; SMN2 (0.66) SMN1; SMN2CASP3SENP7SENP6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198212-A1 ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2021-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198212-A1 ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DISPLAY DEVICE USING THE SAME OCIAD2, OCIAD1, TRPC1 SMN1; SMN2 2163/4885CASP3 3036/4885SENP7 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback